Pharmacology and Toxicology
-
Ozone exposure upregulates the expression of host susceptibility protein TMPRSS2 to SARS-CoV-2
This article has 5 authors:Reviewed by ScreenIT
-
In vitro efficacy of Artemisinin-based treatments against SARS-CoV-2
This article has 12 authors:Reviewed by ScreenIT
-
Platycodin D prevents both lysosome- and TMPRSS2-driven SARS-CoV-2 infection in vitro by hindering membrane fusion
This article has 14 authors:Reviewed by ScreenIT
-
Lipid nanoparticle formulation of niclosamide (nano NCM) effectively inhibits SARS-CoV-2 replication in vitro
This article has 9 authors:Reviewed by ScreenIT
-
Molecular determinants of vascular transport of dexamethasone in COVID-19 therapy
This article has 9 authors:Reviewed by ScreenIT
-
Human embryonic stem cell-derived cardiomyocytes express SARS-CoV-2 host entry proteins: screen to identify inhibitors of infection
This article has 14 authors:Reviewed by ScreenIT
-
Sofosbuvir terminated RNA is more resistant to SARS-CoV-2 proofreader than RNA terminated by Remdesivir
This article has 9 authors:Reviewed by ScreenIT
-
Boceprevir, calpain inhibitors II and XII, and GC-376 have broad-spectrum antiviral activity against coronaviruses in cell culture
This article has 6 authors:Reviewed by ScreenIT
-
Identification of 14 Known Drugs as Inhibitors of the Main Protease of SARS-CoV-2
This article has 9 authors:Reviewed by ScreenIT
-
Identification of SARS-CoV-2 3CL Protease Inhibitors by a Quantitative High-throughput Screening
This article has 10 authors:Reviewed by ScreenIT